UNSPSC 85816306: Introduction of autologous pancreatic islet cells into peripheral vein, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of autologous pancreatic islet cells into peripheral vein, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E033U0

UNSPSC 85816306 Introduction of autologous pancreatic islet cells into peripheral vein, percutaneous approach is a Commodity code that shows little relevant recent activity. The code's abstract description—a specialized endocrinology procedure—does not align with the actual work state and local governments are soliciting under this designation. Recent postings tagged to this code instead cover virtual urgent care services, general medical services, occupational health screening, employee wellness programs, and behavioral health treatment—none involving pancreatic islet cell therapy or specialized diabetes interventions at the procedure level.

The mismatch between the code's nominal scope and current procurement activity suggests either systematic misclassification in state and local procurement systems or that the code's usage has diverged substantially from its intended meaning. Without evidence of genuine market activity for pancreatic islet procedures among state and local buyers, this code carries minimal signal value for business development professionals focused on realistic procurement opportunities. State and local health agencies appear to be using this code as a catch-all health services classification rather than as a precise procedural taxonomy, rendering it unsuitable for targeted pipeline development.